How could mRNA vaccines affect Cosentyx (secukinumab) effectiveness?
Cosentyx is a biologic therapy that targets interleukin-17A (IL‑17A), which helps control immune-driven inflammation in conditions like psoriasis and psoriatic arthritis. mRNA COVID-19 vaccines work by instructing cells to make the SARS‑CoV‑2 spike protein, which then triggers an immune response against the virus. These mechanisms are different, so mRNA vaccines do not “boost” or directly change Cosentyx’s IL‑17A pathway.
In practice, the key link is indirect: Cosentyx can change how strongly your immune system responds to vaccinations because it alters immune signaling involved in inflammation and immune activation. That can mean vaccine antibody levels or vaccine effectiveness may be lower than in people not taking Cosentyx, but the vaccine still aims to generate protective immunity.
Does taking Cosentyx make mRNA vaccines work worse against COVID-19?
Because Cosentyx suppresses specific immune activity, people on IL‑17–targeting biologics can have a reduced immune response to some vaccines compared with healthy controls. The extent depends on factors like the underlying disease, other medications (especially systemic immunosuppressants), timing of vaccination relative to dosing, and individual immune differences.
Even if the antibody response is reduced, vaccines can still protect—often through a mix of antibodies and T‑cell immunity—so “less immune response” does not automatically mean “no protection.” What matters clinically is overall protection against infection and severe disease, not antibody titers alone.
Does vaccination change how well Cosentyx controls psoriasis or psoriatic arthritis?
mRNA vaccination is not designed to interfere with Cosentyx’s IL‑17A mechanism, so it does not typically reduce Cosentyx’s effectiveness in controlling skin or joint inflammation in a direct way. Some patients report temporary changes in symptoms after infections or immune activation, but routine mRNA vaccination is generally used alongside biologics because there is no expected pathway where the vaccine reverses IL‑17A blockade.
Timing: should you get the mRNA vaccine before or during Cosentyx treatment?
The question most people search next is whether timing improves vaccine response. The general clinical approach with biologic therapies is to coordinate around dosing schedules to optimize vaccine immunogenicity where possible, but exact recommendations depend on your condition and regimen. In many cases, clinicians vaccinate without stopping biologics, while considering timing if there are special circumstances (such as concurrent immunosuppressive drugs).
If you share your Cosentyx dosing schedule (every 4 weeks vs. every 2 weeks during loading, and whether you take methotrexate or steroids), I can outline what patients and clinicians commonly consider for timing.
What if you’re also on other immunosuppressants with Cosentyx?
The biggest determinants of vaccine response are often other drugs taken with the biologic. Combining Cosentyx with systemic corticosteroids or other immunosuppressants can further blunt vaccine immune responses compared with Cosentyx alone. In that situation, mRNA vaccines can still work, but protection may be more variable.
What side effects are patients asking about when vaccinated on Cosentyx?
Patients commonly worry about flares of psoriasis/arthritis after vaccination and about infection risk. Vaccines do not replace Cosentyx, so the concern is usually whether immune activation after vaccination triggers a short flare. Reported flare patterns are mixed and often depend on disease stability at the time of vaccination and concurrent medications.
Are there guidelines on using mRNA vaccines with IL‑17 biologics like Cosentyx?
Most immunization guidance for people on biologics aims to keep vaccination up to date because protection against COVID‑19 is important, especially when immune responses may be altered by therapy. IL‑17 biologics like secukinumab are typically treated as biologic immune modulators where vaccination is still recommended, with attention to overall immune status and co-medications.
If your goal is “best protection,” what practical steps usually matter most?
What tends to matter most is staying current with recommended COVID-19 vaccine doses/boosters for your age and risk group, and reviewing your full medication list with your clinician to account for other immunosuppressants that could affect vaccine response.
If you tell me which mRNA vaccine you’re considering and your Cosentyx regimen (and any other meds like methotrexate or prednisone), I can give a more targeted, practical answer about what interactions to think about and what tends to influence protection.
Sources
- https://www.cosentyx.com/how-it-works
- https://www.cdc.gov/covid/vaccines/